Local Cytokine Response in <em>Helicobacter pylori</em>-Infected Subjects
Abstract
The host immune response to Helicobacter pylori infection might be of importance with regard to the outcome of infection by this organism, e.g., to explain why only a proportion of infected subjects develop peptic ulcers. In this study we have analyzed the local response of different cytokines—i.e., the proinflammatory interleukin-1β, (IL-1β), IL-6, tumor necrosis factor alpha, and IL-8; the immunoregulatory gamma interferon (IFN-γ); and IL-4; and the anti-inflammatory transforming growth factor beta (TGF-β)—in antral biopsy specimens from H. pylori-infected duodenal ulcer (DU) patients and asymptomatic (AS) carriers (i.e., with chronic gastritis only). For comparison, biopsy specimens from uninfected healthy individuals were also analyzed. An immunohistochemical technique was used to allow quantification of the cytokine responses as well as identification of the cell types associated with the cytokine expression. We found that the levels of all of the studied cytokines except IL-4 were increased in the H. pylori-infected subjects compared to the levels in the healthy individuals. Our results indicate that the antral cytokine response is of the Th1 type since IFN-γ, but not IL-4, was up-regulated both in H. pylori-infected DU patients and in AS carriers. However, there were no significant differences in either proinflammatory or immunoregulatory cytokine levels when H. pylori-infected subjects with and without peptic ulcers were compared. Some of the cytokines, particularly IL-1β and TGF-β, were also found in the gastric mucosae of healthy, uninfected subjects. We also showed that the gastric epithelium contributes substantially to the antral cytokine response of the proinflammatory cytokines IL-1β and IL-6 in addition to IL-8.
Helicobacter pylori causes chronic antral gastritis and peptic ulcers and is associated with gastric adenocarcinoma and primary gastric lymphoma (30, 32, 34). H. pylori infection almost invariably causes chronic gastritis, but only a proportion of the infected subjects develop peptic ulcers. In addition to the possibility that some H. pylori strains might be more ulcerogenic than others, the nature of the host immune response might explain these different outcomes of infection by this organism. The local inflammation in H. pylori infection is characterized by infiltration of neutrophils and specific lymphocytes into the gastric mucosa as well as by increased production of several cytokines (10, 12, 16, 22, 43). Sometimes the infiltrating B and T cells form lymphoid follicles (15).
The immunoregulatory and proinflammatory cytokines induced by H. pylori may influence the nature of the local T-cell response. It is thought that helper T (Th) cells can be divided into two subsets, Th1 and Th2. The Th1 subset promotes cell-mediated immunity by producing mainly interleukin-2 (IL-2) and gamma interferon (IFN-γ), and the Th2 subset, which is important for antibody responses and also for down-regulation of chronic inflammatory reactions, produces IL-4, IL-5, IL-6, and IL-13 (37). The local Th cell response in H. pylori infection is generally held to be of the Th1 type since the levels of IFN-γ, but not IL-4 and IL-5, have been shown to be increased in H. pylori-induced gastritis (20, 24). Furthermore, gastric H. pylori-specific T-cell clones isolated from peptic ulcer patients are more often of the Th1 type than clones isolated from subjects with chronic gastritis only (12).
The gastric mucosal levels of the proinflammatory cytokines IL-1β, IL-6, IL-8, and tumor necrosis factor alpha (TNF-α) have been reported to be increased in H. pylori-infected subjects (26, 29, 43). In particular, the mucosal production of the neutrophil chemotactic and activating factor IL-8 has been suggested to play an important role in H. pylori-associated diseases (3, 8–10). H. pylori strains carrying the pathogenicity island, including the gene encoding the cytotoxin-associated protein (CagA), are more commonly isolated from duodenal ulcer (DU) patients than from infected subjects with chronic gastritis only, and infection with such strains has been found to be correlated with increased IL-8 production both in vivo and in vitro (10, 33). In addition, TNF-α and IL-1β can cause epithelial cell damage and induce epithelial IL-8 expression and therefore might also be of importance for the H. pylori-induced pathology (14). However, the inflammatory effects induced by the proinflammatory cytokines might be counteracted not only by IL-4 but also by locally produced transforming growth factor beta (TGF-β), which has been shown to have anti-inflammatory effects, e.g., inhibition of T cells, endothelial transmigration of neutrophils, and IL-8 production (11, 31, 39). The TGF-β response to H. pylori infection has not been extensively studied, however.
Most previous studies of H. pylori-induced cytokines have focused on detection of cytokine mRNA or quantification of protein in supernatants from in vitro cultures of gastric biopsy specimens, isolated gastric lymphocytes, or gastric epithelial cell lines (5, 19, 26, 29, 43). However, these approaches do not allow determination of either the localization or the nature of the cytokine-producing cells. In particular, the possible contribution of the antral epithelial cells to the cytokine response in H. pylori infection has hitherto not been extensively studied, except for that of IL-8 (8). In this study, we have therefore used immunohistochemical methods allowing identification as well as enumeration of the gastric cells associated with the expression of some of the cytokines which may be of importance for pathological mechanisms of H. pylori infection, i.e., IL-1β, IL-4, IL-6, IL-8, IFN-γ, TNF-α, and TGF-β. This has included a comparison of the expression of these cytokines in antral biopsy specimens from H. pylori-infected DU patients and subjects with chronic gastritis only (i.e., asymptomatic [AS] carriers), as well as from healthy, uninfected subjects, to evaluate whether there is any association between increased levels of one or more cytokines and peptic ulcer disease.
ACKNOWLEDGMENTS
Ulf and Jan Andersson are gratefully acknowledged for their kind and invaluable help in establishing the immunohistochemical technique in our laboratory. We thank Ingela Ahlstedt for excellent technical assistance and the staff at the Gastroenterological Endoscopy Unit, Sahlgrenska University Hospital, for skillful assistance with the biopsy samplings.
This study was financially supported by a grant from Astra Research Center, Boston, Mass.
REFERENCES
References
- 1. Adams R B, Planchon S M, Roche J K. IFN-γ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol. 1993;150:2356–2363.[PubMed]
- 2. Andersson J, Abrams J, Björk L, Funa K, Litton M, Ågren K, Andersson UConcomitant in vivo production of 19 different cytokines in human tonsils. Immunology. 1994;83:16–24.[Google Scholar]
- 3. Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, Fukatsu A, Ichiyama S, Ohta MInterleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol. 1996;91:1150–1156.[PubMed][Google Scholar]
- 4. Bamford K B, Fan X, Crowe S E, Leary J F, Gourley W K, Luthra G K, Brooks E G, Graham D Y, Reyes V E, Ernst P BLymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998;114:482–492.[PubMed][Google Scholar]
- 5. Basso D, Scrigner M, Toma A, Navaglia F, Dimario F, Rugge M, Plebani M. Helicobacter pylori infection enhances mucosal interleukin 1β, interleukin 6, and the soluble receptor of interleukin 2. Int J Clin Lab Res. 1996;26:207–210.[PubMed]
- 6. Bölin I, Lönroth H, Svennerholm A-MIdentification of Helicobacter pylori by immunological dot blot method based on reaction of a species-specific monoclonal antibody with a surface-exposed protein. J Clin Microbiol. 1995;33:381–384.[Google Scholar]
- 7. Covacci A, Rappuoli R PCR amplification of gene sequences from Helicobacter pylori strains. In: Lee A, Mégraud F, editors. Helicobacter pylori: techniques for clinical diagnosis and basic research. W. B. London, United Kingdom: Saunders; 1996. pp. 94–112. [PubMed]
- 8. Crabtree J E, Wyatt J I, Tredjosiewicz L K, Peichl P, Nichols P H, Ramsay N, Primrose J N, Lindley I J DInterleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol. 1994;47:61–66.[Google Scholar]
- 9. Crabtree J E, Xiang Z, Lindley I J, Tompkins D S, Rappuoli R, Covacci AInduction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol. 1995;48:967–969.[Google Scholar]
- 10. Crabtree J EImmune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol Suppl. 1996;215:3–10.[PubMed][Google Scholar]
- 11. Czarniecki C W, Chiu H H, Wong G H, McCabe S M, Palladino M ATransforming growth factor beta 1 modulates the expression of class II histocompatability antigens on human cells. J Immunol. 1988;140:4217–4223.[PubMed][Google Scholar]
- 12. D’Elios M M, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, Baldari C T, Romagagni S, Telford J L, Del Prete GDifferent cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol. 1997;27:1751–1755.[PubMed][Google Scholar]
- 13. Engstrand L, Scheynius A, Påhlson C, Grimelius L, Schwan A, Gustavsson SAssociation of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun. 1989;57:827–832.[Google Scholar]
- 14. Ernst, P. B., S. E. Crowe, and V. E. Reyes. 1997. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 113(Suppl. 6):S35–S42. [[PubMed]
- 15. Genta R M, Gurer I E, Graham D YGastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol. 1993;24:577–583.[PubMed][Google Scholar]
- 16. Genta R MThe immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis. 1997;8:2–11.[PubMed][Google Scholar]
- 17. Hamlet A K, Erlandsson K I, Olbe L, Svennerholm A-M, Backman V E, Pettersson A BA simple, rapid, and highly reliable capsule-based C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol. 1995;30:1058–1063.[PubMed][Google Scholar]
- 18. Hatz R A, Meimarakis E, Bayerdörffer E, Stolte M, Kirchner T, Enders GCharacterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scan J Gastroenterol. 1996;31:222–228.[PubMed][Google Scholar]
- 19. Huang J, O’Toole P W, Doig P, Trust T JStimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun. 1995;63:1732–1738.[Google Scholar]
- 20. Karttunen R, Karttunen T, Ekre H E, MacDonald T TInterferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 1995;36:341–345.[Google Scholar]
- 21. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989;i:1167–1168.[PubMed]
- 22. Lindholm, C., et al. Unpublished data.
- 23. Mattsson A, Quiding-Järbrink M, Lönroth H, Hamlet A, Ahlstedt I, Svennerholm A-MAntibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun. 1998;66:2705–2712.[Google Scholar]
- 24. Messa C, DiLeo A, Greco B, Caradona L, Amati L, Linsalata M, Giorgio I, Jirillo ESuccessful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. Immunopharmacol Immunotoxicol. 1996;18:1–13.[PubMed][Google Scholar]
- 25. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacter pylori specific cell mediated immune responses display a predominant TH1 phenotype and promote a delayed type hypersensitivity response in the stomachs of mice. J Immunol. 1996;156:4729–4738.[PubMed]
- 26. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn S JMurine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology. 1998;113:1848–1857.[PubMed][Google Scholar]
- 27. Moss S F, Legon S, Davies J, Calam JCytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994;35:1567–1570.[Google Scholar]
- 28. Muller, M. J., and R. H. Hunt. 1993. Cytokines in peptic ulcer disease. Eur. J. Gastroenterol. Hepatol. 5(Suppl. 3):S69–S73.
- 29. Naef M, Ishiwata T, Friess H, Buchler M W, Gold L I, Korc MDifferential localization of transforming growth factor-β isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer. 1997;71:131–137.[PubMed][Google Scholar]
- 30. Noach L A, Bosma N B, Jansen J, Hoek F J, van Deventer S J, Tytgat G NMucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994;29:425–429.[PubMed][Google Scholar]
- 31. Nomura A, Stemmermann G N, Chyou P-H, Kato I, Pérez-Pérez G I, Blaser M J. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med. 1991;325:1132–1136.[PubMed]
- 32. Palladino M A, Morris R E, Starnes H F, Levinson A D. The transforming growth factor-betas. A new family of immunoregulatory molecules. Ann N Y Acad Sci. 1990;593:181–187.[PubMed]
- 33. Parsonnet J, Hansen S, Rodriguez L, Gelb A B, Warnke R A, Jellum E, Orentreich N, Vogelman J H, Friedman G D. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267–1271.[PubMed]
- 34. Peek R M, Jr, Miller G G, Tham K T, Perez-Perez G I, Zhao X, Atherton J C, Blaser M JHeightened inflammatory response and cytokine expression in vivo to cagAHelicobacter pylori strains. Lab Invest. 1995;73:760–770.[PubMed][Google Scholar]
- 35. Peek R M, Jr, Blaser M JPathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med. 1997;102:200–207.[PubMed][Google Scholar]
- 36. Price A BThe Sydney system: histological division. J Gastroenterol Hepatol. 1991;6:209–222.[PubMed][Google Scholar]
- 37. Quiding-Järbrink, M., H. Lönroth, and A.-M. Svennerholm. CD4 and CD8 T cell responses in Helicobacter pylori infected individuals. Submitted for publication.
- 38. Seder R A, Paul W EAcquisition of lymphokine-producing phenotype by CD4 cells. Annu Rev Immunol. 1994;12:635–673.[PubMed][Google Scholar]
- 39. Shirota K, LeDuy L, Yuan S, Jothy SInterleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;58:303–308.[PubMed][Google Scholar]
- 40. Smith W B, Noach L, Khew-Goodall Y, Isenmann S, Vadas M A, Gamble J RTransforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol. 1996;157:360–368.[PubMed][Google Scholar]
- 41. Strober W, Kesall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath MReciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today. 1997;18:61–64.[PubMed][Google Scholar]
- 42. Uehara A, Okumura T, Sekiya C, Okamura K, Takasugi Y, Namiki MInterleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandin. Biochem Biophys Res Commun. 1989;162:1578–1584.[PubMed][Google Scholar]
- 43. Weigert N, Schaffer K, Schusdziarra V, Classen M, Schepp WGastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. Gastroenterology. 1996;110:742–745.[PubMed][Google Scholar]
- 44. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology. 1996;110:1744–1752.[PubMed]


